Traders Sell Shares of Allergan PLC. (AGN) on Strength (AGN)
Traders sold shares of Allergan PLC. (NYSE:AGN) on strength during trading hours on Friday. $164.51 million flowed into the stock on the tick-up and $242.18 million flowed out of the stock on the tick-down, for a money net flow of $77.67 million out of the stock. Of all companies tracked, Allergan PLC. had the 5th highest net out-flow for the day. Allergan PLC. traded up $5.62 for the day and closed at $233.55
Several research firms have recently issued reports on AGN. UBS AG reiterated a “buy” rating and set a $275.00 target price on shares of Allergan PLC. in a report on Monday, May 15th. Vetr raised shares of Allergan PLC. from a “sell” rating to a “hold” rating and set a $242.88 price target for the company in a research report on Monday, June 26th. Wells Fargo & Company reaffirmed an “outperform” rating and issued a $280.00 target price (up previously from $270.00) on shares of Allergan PLC. in a research report on Wednesday, August 9th. Royal Bank Of Canada set a $284.00 target price on shares of Allergan PLC. and gave the stock a “buy” rating in a research report on Sunday, July 16th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and issued a $273.00 target price (up previously from $265.00) on shares of Allergan PLC. in a research report on Monday, July 17th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $275.49.
The stock has a market cap of $78.08 billion, a P/E ratio of 7.12 and a beta of 1.18. The company has a 50-day moving average price of $236.06 and a 200 day moving average price of $237.31.
Allergan PLC. (NYSE:AGN) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $4.02 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.95 by $0.07. The business had revenue of $4.01 billion for the quarter, compared to analyst estimates of $3.95 billion. Allergan PLC. had a net margin of 79.17% and a return on equity of 7.37%. The company’s revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the firm posted $3.35 EPS. On average, analysts predict that Allergan PLC. will post $16.27 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Friday, August 18th will be issued a $0.70 dividend. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $2.80 annualized dividend and a yield of 1.20%. Allergan PLC.’s payout ratio is 9.95%.
A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Allergan PLC. by 2.2% during the second quarter. Vanguard Group Inc. now owns 22,835,689 shares of the company’s stock worth $5,551,128,000 after buying an additional 482,220 shares in the last quarter. Northern Trust Corp lifted its stake in Allergan PLC. by 8.8% during the second quarter. Northern Trust Corp now owns 4,492,944 shares of the company’s stock worth $1,092,189,000 after purchasing an additional 364,722 shares during the last quarter. Veritas Asset Management LLP bought a new position in Allergan PLC. during the first quarter worth $761,339,000. Edgewood Management LLC lifted its stake in Allergan PLC. by 7.0% during the first quarter. Edgewood Management LLC now owns 2,704,211 shares of the company’s stock worth $646,090,000 after purchasing an additional 178,055 shares during the last quarter. Finally, Epoch Investment Partners Inc. lifted its stake in Allergan PLC. by 3.8% during the first quarter. Epoch Investment Partners Inc. now owns 2,013,415 shares of the company’s stock worth $481,045,000 after purchasing an additional 73,081 shares during the last quarter. 82.06% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY WARNING: “Traders Sell Shares of Allergan PLC. (AGN) on Strength (AGN)” was first posted by Daily Political and is the property of of Daily Political. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/09/08/traders-sell-shares-of-allergan-plc-agn-on-strength-agn.html.
Allergan PLC. Company Profile
Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.